Prospective study of barrier contraception for the prevention of sexually transmitted diseases study design and general characteristics of the study group

被引:24
作者
Macaluso, M
Artz, L
Kelaghan, J
Austin, H
Fleenor, M
Hook, EW
机构
[1] Univ Alabama, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA
[2] NICHHD, Contracept & Reprod Hlth Branch, Bethesda, MD 20892 USA
[3] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA
[4] Jefferson Cty Dept Hlth, Birmingham, AL USA
[5] Univ Alabama, Sch Med, Dept Med, Div Infect Dis, Birmingham, AL USA
关键词
D O I
10.1097/00007435-199903000-00002
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background and Objectives: The AIDS epidemic has brought barrier contraceptives to the forefront of public health research. A comprehensive evaluation of the efficacy of barrier contraceptive use in preventing sexually transmitted diseases (STDs), including AIDS, is necessary to inform both potential users and public health policy makers. This study was undertaken to evaluate the efficacy of condoms and vaginal spermicide products, used alone or in combination, in preventing gonorrhea and chlamydia among women attending an STD clinic. Goal of this Study: To describe the general characteristics of the study group and its follow-up experience. Study Design: Women who met the eligibility criteria were invited to participate. The initial visit included an interview, a behavioral intervention promoting barrier methods, a physical examination, and instructions to complete a sexual diary. Participants received free barrier contraceptives and returned for six monthly follow-up visits. Design Results: Participants (n = 1,122) were low income, single (74%) black (89%) women with a median age of 24, The behavioral intervention led to the use of barrier protection in more than 70% of reported acts of vaginal intercourse. Barriers were used consistently (100% of sexual acts) during 51% of the months of follow-up, A total of 148 cases of gonorrhea (28 per 1,000 months) and 122 cases of chlamydia infection (23 cases per 1,000 months) were diagnosed during follow-up. Conclusion: This Study represents a practical solution to a complex set of design considerations. The study protocol was successful in promoting consistent and proper use of barrier methods.
引用
收藏
页码:127 / 136
页数:10
相关论文
共 50 条
[1]   USE OF SPERMICIDE CONTAINING NONOXYNOL-9 PROVIDES SUBSTANTIAL PROTECTION AGAINST GONORRHEAL INFECTION [J].
ALTHAUS, F .
FAMILY PLANNING PERSPECTIVES, 1994, 26 (05) :234-235
[2]   NONSPECIFIC VAGINITIS - DIAGNOSTIC-CRITERIA AND MICROBIAL AND EPIDEMIOLOGIC ASSOCIATIONS [J].
AMSEL, R ;
TOTTEN, PA ;
SPIEGEL, CA ;
CHEN, KCS ;
ESCHENBACH, D ;
HOLMES, KK .
AMERICAN JOURNAL OF MEDICINE, 1983, 74 (01) :14-22
[3]   A FOLLOW-UP-STUDY OF METHODS OF CONTRACEPTION, SEXUAL-ACTIVITY, AND RATES OF TRICHOMONIASIS, CANDIDIASIS, AND BACTERIAL VAGINOSIS [J].
BARBONE, F ;
AUSTIN, H ;
LOUV, WC ;
ALEXANDER, WJ .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1990, 163 (02) :510-514
[4]  
BARLOW D, 1977, LANCET, V2, P811
[5]   INHIBITION OF GROWTH OF CHLAMYDIA-TRACHOMATIS BY NONOXYNOL-9 INVITRO [J].
BENES, S ;
MCCORMACK, WM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 27 (05) :724-726
[6]   IN-VITRO EFFECTS OF EMKO ON NEISSERIA GONORRHOEAE AND TRICHOMONAS-VAGINALIS [J].
BOLCH, OH ;
WARREN, JC .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1973, 115 (08) :1145-1148
[7]   COMPARATIVE IN-VITRO STUDY OF CONTRACEPTIVE AGENTS WITH ANTI-HIV ACTIVITY - GRAMICIDIN, NONOXYNOL-9, AND GOSSYPOL [J].
BOURINBAIAR, AS ;
LEEHUANG, S .
CONTRACEPTION, 1994, 49 (02) :131-137
[8]  
CAREW B, 1996, AM PUBL HLTH ASS NOV
[9]   EFFECTIVENESS OF LATEX CONDOMS AS A BARRIER TO HUMAN IMMUNODEFICIENCY VIRUS-SIZED PARTICLES UNDER CONDITIONS OF SIMULATED USE [J].
CAREY, RF ;
HERMAN, WA ;
RETTA, SM ;
RINALDI, JE ;
HERMAN, BA ;
ATHEY, TW .
SEXUALLY TRANSMITTED DISEASES, 1992, 19 (04) :230-234
[10]   HERPES-SIMPLEX VIRUS TRANSMISSION - CONDOM STUDIES [J].
CONANT, MA ;
SPICER, DW ;
SMITH, CD .
SEXUALLY TRANSMITTED DISEASES, 1984, 11 (02) :94-95